Cargando…
The Treatment of Tuberculosis.
The World Health Organization's Stop TB Department has prepared this fourth edition of Treatment of Tuberculosis: Guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition. First, the recommendation...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Geneva :
World Health Organization,
2009.
|
| Edición: | 4th ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn662259096 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr |n|---||||| | ||
| 008 | 100906s2009 sz o 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d OCLCQ |d ZCU |d XFH |d OCLCF |d MERUC |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d ICG |d AU@ |d OCLCO |d OCLCQ |d OCLCA |d DKC |d OCLCQ |d OCLCO |d OCLCQ |d OCLCA |d OCLCO |d OCLCQ |d OCL |d OCLCO | ||
| 019 | |a 994601696 | ||
| 020 | |a 9789240685352 | ||
| 020 | |a 9240685359 | ||
| 020 | |a 9241547839 | ||
| 020 | |a 9789241547833 | ||
| 029 | 1 | |a AU@ |b 000048823383 | |
| 029 | 1 | |a DEBBG |b BV044146511 | |
| 035 | |a (OCoLC)662259096 |z (OCoLC)994601696 | ||
| 050 | 4 | |a RC311.3.C45 .T74 2009 | |
| 082 | 0 | 4 | |a 616.995061 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Organization, World Health. | |
| 245 | 1 | 4 | |a The Treatment of Tuberculosis. |
| 250 | |a 4th ed. | ||
| 260 | |a Geneva : |b World Health Organization, |c 2009. | ||
| 300 | |a 1 online resource (159 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 505 | 0 | |a COVER; COPYRIGHT; Contents; Abbreviations; Acknowledgements; Foreword; Executive summary; Introduction; Case definitions; Standard treatment regimens; Monitoring during treatment; Co-management of HIV and active TB disease; Supervision and patient support; Treatment of drug-resistant tuberculosis; Treatment of extrapulmonary TB and of TB in special situations; Annexes; Essential first-line antituberculosis drugs; Summary of evidence and considerations underlying the recommendations; TB treatment outcomes; Suggestions for future research. | |
| 588 | 0 | |a Print version record. | |
| 520 | |a The World Health Organization's Stop TB Department has prepared this fourth edition of Treatment of Tuberculosis: Guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition. First, the recommendation to discontinue the regimen based on just 2 months of rifampicin (2HRZE/6HE) and change to the regimen based on a full 6 months of rifampicin (2HRZE/4HR) will reduce the number of relapses and failures. This will alleviate patient suffering resulting from a second episode of tuberculosis (TB) and conserve. | ||
| 546 | |a English. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Chemotherapy. | |
| 650 | 0 | |a Antitubercular agents. | |
| 650 | 0 | |a Tuberculosis. | |
| 650 | 0 | |a Patient compliance. | |
| 650 | 0 | |a Respiratory infections. | |
| 650 | 0 | |a Lungs |x Diseases. | |
| 650 | 0 | |a Therapeutics. | |
| 650 | 0 | |a Health behavior. | |
| 650 | 0 | |a Health planning. | |
| 650 | 0 | |a Health attitudes. | |
| 650 | 0 | |a Human behavior. | |
| 650 | 0 | |a Anti-infective agents. | |
| 650 | 0 | |a Respiratory organs |x Diseases. | |
| 650 | 0 | |a Mycobacterial diseases. | |
| 650 | 0 | |a Health insurance. | |
| 650 | 0 | |a National health insurance. | |
| 650 | 0 | |a Medical care. | |
| 650 | 0 | |a Diseases. | |
| 650 | 0 | |a Gram-positive bacterial infections. | |
| 650 | 0 | |a Bacterial diseases. | |
| 650 | 2 | |a Respiratory Tract Infections | |
| 650 | 2 | |a Anti-Bacterial Agents | |
| 650 | 2 | |a Patient Acceptance of Health Care | |
| 650 | 2 | |a Publication Formats | |
| 650 | 2 | |a Lung Diseases | |
| 650 | 2 | |a Therapeutics | |
| 650 | 2 | |a Tuberculosis | |
| 650 | 2 | |a Health Behavior | |
| 650 | 2 | |a Health Planning | |
| 650 | 2 | |a Attitude to Health | |
| 650 | 2 | |a Behavior | |
| 650 | 2 | |a Anti-Infective Agents | |
| 650 | 2 | |a Publication Characteristics | |
| 650 | 2 | |a Respiratory Tract Diseases | |
| 650 | 2 | |a Analytical, Diagnostic and Therapeutic Techniques and Equipment | |
| 650 | 2 | |a Mycobacterium Infections | |
| 650 | 2 | |a Health Care Economics and Organizations | |
| 650 | 2 | |a Patient Compliance | |
| 650 | 2 | |a Guideline | |
| 650 | 2 | |a Drug Therapy | |
| 650 | 2 | |a Antitubercular Agents | |
| 650 | 2 | |a Tuberculosis, Pulmonary | |
| 650 | 2 | |a National Health Programs | |
| 650 | 2 | |a Delivery of Health Care | |
| 650 | 2 | |a Therapeutic Uses | |
| 650 | 2 | |a Disease | |
| 650 | 2 | |a Actinomycetales Infections | |
| 650 | 2 | |a Behavior and Behavior Mechanisms | |
| 650 | 2 | |a Psychiatry and Psychology | |
| 650 | 2 | |a Gram-Positive Bacterial Infections | |
| 650 | 2 | |a Pharmacologic Actions | |
| 650 | 2 | |a Health Care Quality, Access, and Evaluation | |
| 650 | 2 | |a Chemical Actions and Uses | |
| 650 | 2 | |a Bacterial Infections | |
| 650 | 2 | |a Bacterial Infections and Mycoses | |
| 650 | 2 | |a Chemicals and Drugs | |
| 650 | 2 | |a Antibiotics, Antitubercular | |
| 650 | 2 | |a Respiration Disorders | |
| 650 | 2 | |a Insurance, Health | |
| 650 | 2 | |a Patient Care | |
| 650 | 6 | |a Chimiothérapie. | |
| 650 | 6 | |a Antituberculeux. | |
| 650 | 6 | |a Tuberculose. | |
| 650 | 6 | |a Patients |x Coopération. | |
| 650 | 6 | |a Appareil respiratoire |x Infections. | |
| 650 | 6 | |a Poumons |x Maladies. | |
| 650 | 6 | |a Thérapeutique. | |
| 650 | 6 | |a Habitudes sanitaires. | |
| 650 | 6 | |a Santé publique |x Planification. | |
| 650 | 6 | |a Attitudes à l'égard de la santé. | |
| 650 | 6 | |a Comportement humain. | |
| 650 | 6 | |a Antiinfectieux. | |
| 650 | 6 | |a Appareil respiratoire |x Maladies. | |
| 650 | 6 | |a Mycobactérioses. | |
| 650 | 6 | |a Assurance-maladie. | |
| 650 | 6 | |a Prestation de soins. | |
| 650 | 6 | |a Maladies. | |
| 650 | 6 | |a Infections à bactéries Gram positives. | |
| 650 | 6 | |a Maladies bactériennes. | |
| 650 | 6 | |a Soins médicaux. | |
| 650 | 7 | |a human behavior. |2 aat | |
| 650 | 7 | |a illness. |2 aat | |
| 650 | 7 | |a disease. |2 aat | |
| 650 | 7 | |a treating (health care function) |2 aat | |
| 650 | 7 | |a Therapeutics |2 fast | |
| 650 | 7 | |a Respiratory organs |x Diseases |2 fast | |
| 650 | 7 | |a Respiratory infections |2 fast | |
| 650 | 7 | |a National health insurance |2 fast | |
| 650 | 7 | |a Mycobacterial diseases |2 fast | |
| 650 | 7 | |a Medical care |2 fast | |
| 650 | 7 | |a Lungs |x Diseases |2 fast | |
| 650 | 7 | |a Human behavior |2 fast | |
| 650 | 7 | |a Health planning |2 fast | |
| 650 | 7 | |a Health insurance |2 fast | |
| 650 | 7 | |a Health behavior |2 fast | |
| 650 | 7 | |a Health attitudes |2 fast | |
| 650 | 7 | |a Gram-positive bacterial infections |2 fast | |
| 650 | 7 | |a Diseases |2 fast | |
| 650 | 7 | |a Bacterial diseases |2 fast | |
| 650 | 7 | |a Anti-infective agents |2 fast | |
| 650 | 7 | |a Antitubercular agents |2 fast | |
| 650 | 7 | |a Chemotherapy |2 fast | |
| 650 | 7 | |a Patient compliance |2 fast | |
| 650 | 7 | |a Tuberculosis |2 fast | |
| 776 | 0 | 8 | |i Print version: |a Organization, World Health. |t Treatment of Tuberculosis: Guidelines. |d Geneva : World Health Organization, ©2009 |z 9789241547833 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=579104 |z Texto completo |
| 938 | |a EBL - Ebook Library |b EBLB |n EBL579104 | ||
| 994 | |a 92 |b IZTAP | ||